Product: Acuvue Oasys Max 1-Day
Top Line: Johnson & Johnson Vision Care today announced the launch of its newest innovation, Acuvue Oasys Max 1-Day contact lenses and Acuvue Oasys Max 1-Day Multifocal contact lenses for presbyopia.
Close Up: The lenses are designed with new technologies to help meet the needs of digitally intense lifestyles: TearStable Technology and OptiBlue light filter. TearStable Technology is designed to maximize tear-film stability and lock in moisture for exceptional all-day comfort. The OptiBlue light filter has the highest level blue-violet filter in the industry at 60 percent, to reduce light scatter for exceptional visual clarity, day to night. In addition, Acuvue Oasys Max 1-Day lenses block 99.9 percent UVA rays and 100 percent UVB rays.
“Life has changed, post-pandemic. With more time spent on digital devices, we designed these contact lenses by listening to patients and eyecare professionals’ feedback to address lifestyle requirements and help prevent dry and tired eyes from becoming normalized,” said John Buch, OD, senior principal research optometrist, Johnson & Johnson Vision. “Our new Acuvue Oasys Max 1-Day contact lenses help reduce discomfort by providing visual clarity with new technologies to filter blue-violet light, which comes from many sources, including digital screens and travels in short wavelengths and scatters more which can lead to eye discomfort and quality of vision.” Earlier this year, Acuvue Oasys Max 1-Day And Acuvue Oasys Max 1-Day Multifocal received U.S. Food & Drug Administration clearance, Health Canada approval and completed CE Mark activities for its latest contact lens innovation.
Vital Stats: The lenses are available now in spherical and multifocal.